NSP-1047-A

N/A

Report date: 2025/02/26 13:21:45
NME

Base Information

Drug NameNSP-1047-A
Drug Alias NameNSP-1047ANSP-1047-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 4E inhibitorsMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors
TargetsEukaryotic translation initiation factor 4EMAP kinase-interacting serine/threonine-protein kinase MNK1MAP kinase-interacting serine/threonine-protein kinase 2
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNuowo Sida Pharmaceutical (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNuowo Sida Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A